Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: 18 - The Real Truth

Researchers test mRNA technology for universal flu vaccine

An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.

Reuters

US renews push for COVID boosters as data show they protect

Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now

The Independent UK

RSV: experts explain why rates of this virus are surging this year

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer booster spurs immune response to new omicron subtypes

Pfizer said its updated COVID-19 booster may offer some protection against newly emerging omicron mutants even though it’s not an exact match

The Independent UK

Moderna’s bivalent shot boosts antibodies against latest omicron strains in trial

Moderna Inc.’s booster shot of its bivalent vaccine sharply increased antibody levels against recent COVID-19 strains when compared to a fourth dose of its original immunization.

Tribune News Service

Lordstown Motors, eBay And 2 Other Stocks Insiders Are Selling

The Nasdaq Composite jumped over 750 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Check Out What Whales Are Doing With MRNA

Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas

For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.

Tribune News Service

Vulnerable Australians want access to another booster dose. Here's the state of play across the country

As COVID cases rise across the country, there are calls for additional booster doses to be made available to Australians who want it.

ABC News

Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune

While sales of its COVID vaccines are falling, Pfizer plans to triple the price of the shots and use its bonanza from government contracts to buy and develop new blockbusters.

Fortune

Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.

Benzinga

The ProPublica-Vanity Fair report on Covid’s origins is explosive. Is it reliable?

Critics say the article is flawed. But that shouldn’t discredit the lab leak theory

The Guardian - US

This Is What Whales Are Betting On Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

PepsiCo, Walmart And 2 Other Stocks Insiders Are Selling

The Nasdaq Composite gained by over 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Moderna Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 17 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022

Upgrades

Tribune News Service

As links to MS deepen, researchers accelerate efforts to develop an Epstein-Barr vaccine

Maybe you’ve never heard of the Epstein-Barr virus. But it knows all about you.

The Independent UK

Moderna jab ‘to protect through the winter’ after positive new results

The main Covid-19 booster offers good protection for at least three months.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Updated Moderna Covid booster gives even better protection than earlier jab

Biotech firm’s data shows stronger immune response to Omicron than original vaccine three months after being given

Chronicle Live

Covid winter boosters, new vaccines and why side effects may be different

Everybody over 50 is invited for a winter coronavirus jab but not everybody will get the new dual/bivalent vaccines that target multiple strains

Tribune News Service

Moderna to supply 100 million COVID vaccines to poor countries

Moderna Inc. will provide as many as 100 million doses of COVID-19 shots that specifically target variants for vaccine alliance Gavi to distribute in lower-income countries in 2023.

Benzinga

Check Out What Whales Are Doing With MRNA

Asharq Al-Awsat

Moderna Signs Deal on Variant-Adapted COVID Shots for World’s Poorest

Moderna Inc has agreed to provide its new variant-adapted COVID-19 vaccine to the global scheme aiming to deliver shots to the world's poorest people. The biotech company and vaccine alliance GAVI will cancel their existing supply deal for vaccines based on the original coronavirus strain. Instead, Moderna will supply up…

ABC News

What vaccine can you get, based on your age? These are the recommended COVID-19 vaccines for each age group

More than 14.2 million Australians over the age of 16 have now received three or more doses. So which are the best vaccines for each age group?

Daily Mirror

Breakthrough cancer vaccine could be ready in months, say scientists

Manufacturers Moderna and Merck are testing a breakthrough cancer vaccine for patients suffering from melanoma which kills thousands of people each year in the UK

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

UK Health Security Agency

509 stories

Piper Sandler

427 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.